Tilray Initiates Roundtable With German Regulators to : vima

BERLIN, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and...

Related Keywords

United States , Germany , Portugal , Australia , New Zealand , Canada , Berlin , America , Canadian , German , Raphael Gross , Burkhard Blienert , Tilray Europe , Carlos Kasper , Denise Faltischek , Berrin Noorata , Martina Stamm Fibich , Clemens Reisbeck , Company Nasdaq , Committee On , Head Of International , Ministry Of Health , Committee On Health , Nasdaq , Securities Exchange , Tilray Brands Inc , German Drug Commissioner , Narcotic Drugs , Federal Ministry , Drug Policy , Chief Strategy Officer , Tilray Brands , Managing Director , European Good Manufacturing Practice , North America , Tilray Medical , Broken Coast , Tilray Medical Europe , Tilray Medical Canada , Tilray Medical Australia , Tilray Medical Australia New , Latin America , Securities Act , Securities Exchange Act , Annual Report , Nasdaq Tlry , Nc , Europe Medical Cannabis , Medical Cannabis , Cannabis Legalization , Cannabis Regulations , Tilray , U Gmp , Dult Use Cannabis Germany ,